 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              A Meeting of the Board of Directors of Kilitch Drugs India Ltd will be held on Thursday , March 29, 2018 to consider the conversion of 5,00,000 Warrants issued at a price of Rs. 59/- per warrant and allotment of 5,00,000 Equity shares of face value of Rs. 10/- each pursuant to such conversion of Warrants.
Shares of KILITCH DRUGS (INDIA) LTD. was last trading in BSE at Rs.78.95 as compared to the previous close of Rs. 80.6. The total number of shares traded during the day was 15054 in over 72 trades.
The stock hit an intraday high of Rs. 83.35 and intraday low of 78.05. The net turnover during the day was Rs. 1228026.